Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Filing (0001209191-20-039272)

Filing Details

Accession Number:
0001209191-20-039272
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-06-29 20:13:05
Reporting Period:
2020-06-25
Accepted Time:
2020-06-29 20:13:05
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1419041 Forte Biosciences Inc. FBRX Pharmaceutical Preparations (2834) 261243872
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1612842 A. Paul Wagner C/O Forte Biosciences, Inc.
1124 W. Carson Street, Mrl Bldg. 3-320
Torrance CA 90502		 See Remarks Yes Yes Yes No
Reported Non-Derivative Transactions
Show Other Fields >>
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-06-25 7,000 $14.48 2,279,049 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Represents the weighted average share price of an aggregate total of 7,000 shares purchased in the price range of $14.1620 to $14.9899 by the Reporting Person. The Reporting Person undertakes to provide upon requestby the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.